ERBB2 and ovarian carcinoma: We highlighted a leading protein–protein interaction (PPI) network underlying breast, endometrial, and ovarian cancers centered on the oncogene Erb-B2 Receptor Tyrosine Kinase 2 (ERBB2) [11].